Copyright Reports & Markets. All rights reserved.

Global Radiopharmaceutical Injector Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Radiopharmaceutical Injector Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 PET Radioactive Drugs Injector
    • 1.3.3 PET and SPECT Radioactive Drugs Injector
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Radiopharmaceutical Injector Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 R&D Institution
  • 1.5 Global Radiopharmaceutical Injector Market Size & Forecast
    • 1.5.1 Global Radiopharmaceutical Injector Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Radiopharmaceutical Injector Sales Quantity (2021-2032)
    • 1.5.3 Global Radiopharmaceutical Injector Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medrad, Inc.(Bayer)
    • 2.1.1 Medrad, Inc.(Bayer) Details
    • 2.1.2 Medrad, Inc.(Bayer) Major Business
    • 2.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product and Services
    • 2.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medrad, Inc.(Bayer) Recent Developments/Updates
  • 2.2 UNIVERSAL GIKEN
    • 2.2.1 UNIVERSAL GIKEN Details
    • 2.2.2 UNIVERSAL GIKEN Major Business
    • 2.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Product and Services
    • 2.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 UNIVERSAL GIKEN Recent Developments/Updates
  • 2.3 Comecer
    • 2.3.1 Comecer Details
    • 2.3.2 Comecer Major Business
    • 2.3.3 Comecer Radiopharmaceutical Injector Product and Services
    • 2.3.4 Comecer Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Comecer Recent Developments/Updates
  • 2.4 Sumitomo Heavy Industries
    • 2.4.1 Sumitomo Heavy Industries Details
    • 2.4.2 Sumitomo Heavy Industries Major Business
    • 2.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Product and Services
    • 2.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sumitomo Heavy Industries Recent Developments/Updates
  • 2.5 Tema Sinergie
    • 2.5.1 Tema Sinergie Details
    • 2.5.2 Tema Sinergie Major Business
    • 2.5.3 Tema Sinergie Radiopharmaceutical Injector Product and Services
    • 2.5.4 Tema Sinergie Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Tema Sinergie Recent Developments/Updates
  • 2.6 Lemer Pax
    • 2.6.1 Lemer Pax Details
    • 2.6.2 Lemer Pax Major Business
    • 2.6.3 Lemer Pax Radiopharmaceutical Injector Product and Services
    • 2.6.4 Lemer Pax Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Lemer Pax Recent Developments/Updates
  • 2.7 BQSV
    • 2.7.1 BQSV Details
    • 2.7.2 BQSV Major Business
    • 2.7.3 BQSV Radiopharmaceutical Injector Product and Services
    • 2.7.4 BQSV Radiopharmaceutical Injector Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BQSV Recent Developments/Updates

3 Competitive Environment: Radiopharmaceutical Injector by Manufacturer

  • 3.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Radiopharmaceutical Injector Revenue by Manufacturer (2021-2026)
  • 3.3 Global Radiopharmaceutical Injector Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Radiopharmaceutical Injector by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Radiopharmaceutical Injector Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Radiopharmaceutical Injector Manufacturer Market Share in 2025
  • 3.5 Radiopharmaceutical Injector Market: Overall Company Footprint Analysis
    • 3.5.1 Radiopharmaceutical Injector Market: Region Footprint
    • 3.5.2 Radiopharmaceutical Injector Market: Company Product Type Footprint
    • 3.5.3 Radiopharmaceutical Injector Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Radiopharmaceutical Injector Market Size by Region
    • 4.1.1 Global Radiopharmaceutical Injector Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Radiopharmaceutical Injector Consumption Value by Region (2021-2032)
    • 4.1.3 Global Radiopharmaceutical Injector Average Price by Region (2021-2032)
  • 4.2 North America Radiopharmaceutical Injector Consumption Value (2021-2032)
  • 4.3 Europe Radiopharmaceutical Injector Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Radiopharmaceutical Injector Consumption Value (2021-2032)
  • 4.5 South America Radiopharmaceutical Injector Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Radiopharmaceutical Injector Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Radiopharmaceutical Injector Sales Quantity by Type (2021-2032)
  • 5.2 Global Radiopharmaceutical Injector Consumption Value by Type (2021-2032)
  • 5.3 Global Radiopharmaceutical Injector Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Radiopharmaceutical Injector Sales Quantity by Application (2021-2032)
  • 6.2 Global Radiopharmaceutical Injector Consumption Value by Application (2021-2032)
  • 6.3 Global Radiopharmaceutical Injector Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Radiopharmaceutical Injector Sales Quantity by Type (2021-2032)
  • 7.2 North America Radiopharmaceutical Injector Sales Quantity by Application (2021-2032)
  • 7.3 North America Radiopharmaceutical Injector Market Size by Country
    • 7.3.1 North America Radiopharmaceutical Injector Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Radiopharmaceutical Injector Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Radiopharmaceutical Injector Sales Quantity by Type (2021-2032)
  • 8.2 Europe Radiopharmaceutical Injector Sales Quantity by Application (2021-2032)
  • 8.3 Europe Radiopharmaceutical Injector Market Size by Country
    • 8.3.1 Europe Radiopharmaceutical Injector Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Radiopharmaceutical Injector Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Radiopharmaceutical Injector Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Radiopharmaceutical Injector Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Radiopharmaceutical Injector Market Size by Region
    • 9.3.1 Asia-Pacific Radiopharmaceutical Injector Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Radiopharmaceutical Injector Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Radiopharmaceutical Injector Sales Quantity by Type (2021-2032)
  • 10.2 South America Radiopharmaceutical Injector Sales Quantity by Application (2021-2032)
  • 10.3 South America Radiopharmaceutical Injector Market Size by Country
    • 10.3.1 South America Radiopharmaceutical Injector Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Radiopharmaceutical Injector Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Radiopharmaceutical Injector Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Radiopharmaceutical Injector Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Radiopharmaceutical Injector Market Size by Country
    • 11.3.1 Middle East & Africa Radiopharmaceutical Injector Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Radiopharmaceutical Injector Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Radiopharmaceutical Injector Market Drivers
  • 12.2 Radiopharmaceutical Injector Market Restraints
  • 12.3 Radiopharmaceutical Injector Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Radiopharmaceutical Injector and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Radiopharmaceutical Injector
  • 13.3 Radiopharmaceutical Injector Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Radiopharmaceutical Injector Typical Distributors
  • 14.3 Radiopharmaceutical Injector Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Radiopharmaceutical Injector market size was valued at US$ 35.29 million in 2025 and is forecast to a readjusted size of US$ 57.02 million by 2032 with a CAGR of 7.2% during review period.
    A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
    The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient"s body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient"s body and accurate imaging or therapeutic results.
    Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
    This report is a detailed and comprehensive analysis for global Radiopharmaceutical Injector market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Radiopharmaceutical Injector market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Radiopharmaceutical Injector market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Radiopharmaceutical Injector market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Radiopharmaceutical Injector market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Radiopharmaceutical Injector
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Radiopharmaceutical Injector market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Radiopharmaceutical Injector market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    PET Radioactive Drugs Injector
    PET and SPECT Radioactive Drugs Injector
    Market segment by Application
    Hospitals and Clinics
    R&D Institution
    Major players covered
    Medrad, Inc.(Bayer)
    UNIVERSAL GIKEN
    Comecer
    Sumitomo Heavy Industries
    Tema Sinergie
    Lemer Pax
    BQSV
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Radiopharmaceutical Injector product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Radiopharmaceutical Injector, with price, sales quantity, revenue, and global market share of Radiopharmaceutical Injector from 2021 to 2026.
    Chapter 3, the Radiopharmaceutical Injector competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Radiopharmaceutical Injector breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Radiopharmaceutical Injector market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical Injector.
    Chapter 14 and 15, to describe Radiopharmaceutical Injector sales channel, distributors, customers, research findings and conclusion.

    Buy now